- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The neoepitope landscape of breast cancer: implications for immunotherapy ; volume:19 ; number:1 ; day:4 ; month:3 ; year:2019 ; pages:1-10 ; date:12.2019
BMC cancer ; 19, Heft 1 (4.3.2019), 1-10, 12.2019
- Urheber
-
Narang, Pooja
Chen, Meixuan
Sharma, Amit A.
Anderson, Karen S.
Wilson, Melissa A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-5402-1
- URN
-
urn:nbn:de:101:1-2019033002275645114442
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Narang, Pooja
- Chen, Meixuan
- Sharma, Amit A.
- Anderson, Karen S.
- Wilson, Melissa A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients
Combination Immunotherapy Strategies in Breast Cancer
An update on immunotherapy in breast cancer
Immunotherapy: new options in breast cancer treatment
Emerging nanomedicines for effective breast cancer immunotherapy
Immunotherapy in Breast Cancer: the New Frontier
Current and future immunotherapy for breast cancer
Clinical Data on Immunotherapy in Breast Cancer
Mutational landscape of inflammatory breast cancer
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients
Combination Immunotherapy Strategies in Breast Cancer
An update on immunotherapy in breast cancer
Immunotherapy: new options in breast cancer treatment
Emerging nanomedicines for effective breast cancer immunotherapy
Immunotherapy in Breast Cancer: the New Frontier
Current and future immunotherapy for breast cancer
Clinical Data on Immunotherapy in Breast Cancer
Mutational landscape of inflammatory breast cancer
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients
Combination Immunotherapy Strategies in Breast Cancer
An update on immunotherapy in breast cancer
Immunotherapy: new options in breast cancer treatment
Emerging nanomedicines for effective breast cancer immunotherapy
Immunotherapy in Breast Cancer: the New Frontier
Current and future immunotherapy for breast cancer
Clinical Data on Immunotherapy in Breast Cancer
Mutational landscape of inflammatory breast cancer
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy